Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: Findings from dana-farber cancer institute all consortium protocol 00-01

Pediatric Blood and Cancer

Volumn 60, Issue 11, 2013, Pages 1785-1791

  Waber, Deborah P ^a,b   Mccabe, Marie ^a   Sebree, Mikaela ^a,c   Forbes, Peter W ^a   Adams, Heather ^d   Alyman, Cheryl ^e   Sands, Stephen A ^f   Robaey, Philippe ^g,h   Romero, Ivonne ⁱ   Routhier, Marie Ève ^g   Girard, Jonathan M ^a   Sallan, Stephen E ^a   Silverman, Lewis B ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c St Luke's Children's Hospital   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f Department of Medicine   (Canada)

^g UNIVERSITÉ DE MONTRÉAL   (Canada)

^h UNIVERSITY OF OTTAWA   (Canada)

ⁱ Interamerican University   (United States)

Author keywords

Acute lymphoblastic leukemia; Behavior; Children; Cognition; Dexamethasone

Indexed keywords

DEXAMETHASONE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CENTER; CANCER REGRESSION; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEX RATIO; SPECIAL EDUCATION; TREATMENT DURATION;

ACUTE LYMPHOBLASTIC LEUKEMIA; BEHAVIOR; CHILDREN; COGNITION; DEXAMETHASONE;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; COGNITION; DEXAMETHASONE; FEMALE; HUMANS; INFANT; MALE; NEUROPSYCHOLOGICAL TESTS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE;

EID: 84883828379     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24666     Document Type: Article

References (27)

1. Inaba H, Pui C.-H. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol 2010; 11:1096-1106.
2. Bostrom BC, Sensel MR, Sather HN, et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: A report from the Children's Cancer Group. Blood 2003; 101:3809-3817.
3. Mitchell CD, Richards SM, Kinsey SE, et al. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: Results of the UK Medical Research Council ALL97 randomized trial. Br J Haematol 2005; 129:734-745.
4. Drigan R, Spirito A, Gelber RD. Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia. Med Pediatr Oncol 1992; 20:13-21.
5. Mrakotsky CM, Silverman LB, Dahlberg SE, et al. Neurobehavioral side effects of corticosteroids during active treatment for acute lymphoblastic leukemia in children are age-dependent: Report from Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. Pediatr Blood Cancer 2011; 57:492-498.
6. Waber DP, Carpentieri SC, Klar N, et al. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone [comment]. J Pediatr Hematol Oncol 2000; 22:206-213.
7. Marcoux S, Robaey P, Krajinovic M, et al. Predictive factors of internalized and externalized behavioral problems in children treated for acute lymphoblastic leukemia. Pediatr Blood Cancer 2012; 58:971-977.
8. Kadan-Lottick NS, Brouwers P, Breiger D, et al. A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemia. Blood 2009; 114:1746-1752.
9. Eiser C, Davies H, Jenney M, et al. HRQOL implications of treatment with dexamethasone for children with acute lymphoblastic leukemia (ALL). Pediatric Blood Cancer 2006; 46:35-39.
10. Vrooman LM, Stevenson K, Supko JG, et al. Post-induction dexamethasone and individualised dosing of E. coli L-asparaginase each improve outcome of children and adoelscents wtih newly diagnosed acute lymphoblastic leukemia: Results from the Dana-Farber Cancer Institute ALL Consortium Protocol 00-01. J Clin Oncol 2013; 31:1202-10.
11. Packan DR, Sapolsky RM. Glucocorticoid endangerment of the hippocampus: Tissue, steroid and receptor specificity. Neuroendocrinology 1990; 51:613-618.
12. Newcomer JW, Selke G, Melson AK, et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry 1999; 56:527-533.
13. Moghrabi A, Levy DE, Asselin B, et al. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for Children with Acute Lymphoblastic Leukemia. Blood 2007; 109:896-904.
14. Wechsler D. Wechsler Abbreviated Scale of Intelligence. New York: Psychological Corporation; 1999.
15. Waber DP, Silverman LB, Catania L, et al. Outcomes of a randomized trial of hyperfractonated cranial radiation therapy (18Gy) for treatment of high-risk acute lymphoblastic leukemia: Therapeutic efficacy and neurotoxicity. J Clin Oncol 2004; 22:2701-2707.
16. Waber DP, Turek J, Catania L, et al. Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: Findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. J Clin Oncol 2007; 25:4914-4921.
17. Waber DP, Bernstein JH. Performance of learning-disabled and non-learning-disabled children on the Rey-Osterrieth Complex Figure (ROCF): Validation of the developmental scoring system. Dev Neuropsychol 1995; 11:237-252.
18. Waber DP, Shapiro BL, Carpentieri SC, et al. Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia: A 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol 87-01. Cancer 2001; 92:15-22.
19. Spiegler BJ, Kennedy K, Maze R, et al. Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate. J Clin Oncol 2006; 24:3858-3864.
20. Mattano LA, Jr., Devidas M, Nachman JB, et al. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: Results from the CCG-1961 randomised cohort trial. Lancet Oncol 2012; 13:906-915.
21. Wechsler D. Wechsler Intelligence Scale for Children, 4th edition. New York, NY: Psychological Corporation; 2003.
22. Wechsler D. Wechsler Adult Intelligence Scale, 3rd edition. San Antonio, TX: The Psychological Corporation; 1997.
23. Bernstein JH, Waber D. Developmental Scoring System for the Rey-Osterrieth Complex Figure. Odessa, FL: Psychological Assessment Resources; 1996.
24. Reynolds CR, Bigler ED. Test of memory and learning. Austin, TX: Pro-Ed; 1994.
25. Woodcock RW, McGrew KS, Mather N. Woodcock-Johnson III. Itasca, IL: Riverside Publishing; 2001.
26. Reynolds CR, Kampaus RW. Behavior Assessment System for Children, 2nd edition. Circle Pines, MN: American Guidance Service; 2004.
27. Gioia GA, Isquith PK, Guy SC, et al. Behavior rating inventory of executive function. Odessa, FL: Psychoogical Assessment Resources; 2000.